APS
2023 APS Annual Convention · 2023
Cannabidiol May Help to Reduce Relapse Risk By Attenuating Cue-Reactivity in Individuals with Opioid Use Disorder Receiving Buprenorphine or Methadone
- Sara Prostko
Brigham & Women's Hospital, Harvard Medical School - Veronica Szpak
Brigham and Women's Hospital - Peter Chai
The Fenway Institute - Peter Chai
Massachusetts Institute of Technology - Peter Chai
Dana Farber Cancer Institute - Peter Chai
Brigham and Women's Hospital - Peter Chai
Harvard Medical School - Primavera Spagnolo
Harvard Medical School - Primavera Spagnolo
Brigham and Women's Hospital - Saeed Ahmed
Rutland Regional Medical Center - Roger Weiss
McLean Hospital - Roger Weiss
Harvard Medical School - Joji Suzuki
Harvard Medical School - Joji Suzuki
Brigham and Women's Hospital
Abstract
This double-blind, placebo-controlled, cross-over study examined the effects of cannabidiol (CBD) on reward- and stress-related neurocognitive processes among individuals with opioid use disorder. Participants (n=10) received CBD 600mg or matching placebo on two separate days. CBD was associated with a significantly reduced cue-induced craving and attentional bias to drug-related cues.
Substance Abuse and Addiction
